Equifax (NYSE:EFX) Given New $265.00 Price Target at Wells Fargo & Company

Equifax (NYSE:EFX) had its target price reduced by stock analysts at Wells Fargo & Company from $285.00 to $265.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the credit services provider’s stock. Wells Fargo & Company‘s price objective suggests a potential upside of 21.36% from the stock’s previous close.

Several other research firms have also issued reports on EFX. Seaport Res Ptn upgraded shares of Equifax to a “hold” rating in a report on Wednesday, October 1st. Stifel Nicolaus cut their price target on Equifax from $295.00 to $253.00 and set a “buy” rating for the company in a research note on Wednesday, October 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Equifax in a research note on Monday, December 29th. BMO Capital Markets dropped their price target on shares of Equifax from $245.00 to $234.00 and set a “market perform” rating for the company in a research report on Monday, December 8th. Finally, Morgan Stanley cut their target price on Equifax from $290.00 to $280.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $273.07.

Equifax Price Performance

Shares of NYSE:EFX traded up $0.81 during trading on Wednesday, reaching $218.37. The company had a trading volume of 362,740 shares, compared to its average volume of 1,464,973. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.82. The stock has a market capitalization of $26.73 billion, a P/E ratio of 41.42, a price-to-earnings-growth ratio of 2.21 and a beta of 1.56. The company has a fifty day moving average of $214.08 and a two-hundred day moving average of $234.26. Equifax has a 12 month low of $199.98 and a 12 month high of $281.07.

Equifax (NYSE:EFX) last released its earnings results on Tuesday, October 21st. The credit services provider reported $2.04 EPS for the quarter, beating the consensus estimate of $1.94 by $0.10. Equifax had a net margin of 11.08% and a return on equity of 19.28%. The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.52 billion. During the same quarter last year, the firm earned $1.85 EPS. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS and its FY 2025 guidance at 7.550-7.650 EPS. Equities research analysts forecast that Equifax will post 7.58 earnings per share for the current year.

Insiders Place Their Bets

In other Equifax news, EVP Jamil Farshchi sold 4,925 shares of the stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $238.94, for a total transaction of $1,176,779.50. Following the sale, the executive vice president directly owned 39,364 shares of the company’s stock, valued at approximately $9,405,634.16. This trade represents a 11.12% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Mark W. Begor sold 21,386 shares of Equifax stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $231.12, for a total value of $4,942,732.32. Following the transaction, the chief executive officer owned 22,045 shares of the company’s stock, valued at $5,095,040.40. The trade was a 49.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 54,270 shares of company stock worth $12,580,837 in the last quarter. Company insiders own 1.40% of the company’s stock.

Institutional Trading of Equifax

Several hedge funds and other institutional investors have recently bought and sold shares of EFX. CX Institutional lifted its holdings in Equifax by 0.9% in the second quarter. CX Institutional now owns 5,005 shares of the credit services provider’s stock valued at $1,298,000 after acquiring an additional 43 shares during the period. Accretive Wealth Partners LLC increased its holdings in shares of Equifax by 1.1% during the 2nd quarter. Accretive Wealth Partners LLC now owns 4,564 shares of the credit services provider’s stock valued at $1,184,000 after purchasing an additional 48 shares in the last quarter. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Equifax by 12.5% during the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 458 shares of the credit services provider’s stock valued at $117,000 after purchasing an additional 51 shares in the last quarter. HighPoint Advisor Group LLC lifted its stake in shares of Equifax by 2.8% in the 3rd quarter. HighPoint Advisor Group LLC now owns 1,971 shares of the credit services provider’s stock valued at $506,000 after purchasing an additional 53 shares during the period. Finally, Sowell Financial Services LLC boosted its holdings in Equifax by 4.0% during the second quarter. Sowell Financial Services LLC now owns 1,433 shares of the credit services provider’s stock worth $372,000 after buying an additional 55 shares in the last quarter. 96.20% of the stock is owned by institutional investors and hedge funds.

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.